Every week, I am invited on Business First AM with Angela Miles to discuss the market and give a stock pick.
This week, I covered TEVA, a stock I have talked about a few times and one, full disclosure, we …
Probably the worst or at least one of the worst performers in the overall market and in the commodities market, natural gas is choppy and lifeless.
So why write about it?
For starters, we love an underdog. Perhaps a bit …
On July 5th, Mish wrote an article called Sell in July and Go Away? Calendar Range Reset.
One quote from the article, “.should IWM fail to clear the calendar range high and worse, break down under a new 6-month calendar …
This entire year, retail as measured by the ETF XRT or the Granny of the Economic Modern Family has underperformed the SPY and QQQs.
Encumbered by higher interest rates, higher oil prices, higher inflation, higher insurance costs and a burgeoning …
Conference Board Economic Forecast:
Looking into 2024, we expect the volatility that dominated the US economy over the pandemic period to diminish. In the second half of 2024, we forecast that overall growth will return to more stable pre-pandemic rates, …
Bonds have had one of the worst years in modern times and one of the fastest rates of interest rate rises.
The good news is the market has absorbed the bond’s performance.
A better risk-on environment is when the SPY …
Small caps as measured by IWM are key for the fall and into 2024.
You can also look at SML S&P 600.
IWM could be forming an inverted head and shoulders bottom going back from the start of 2023. (see …
Over the course of our writing the Daily, it has served as a reliable and remarkable guide for investors, traders, and investments.
For example, looking most recently, on August 22nd, we wrote about watching the dollar decline and TLTs rising. …
With BRICS happening ahead of Jackson Hole, we thought it would be good to look at the technical charts on both the dollar and the long bonds.
The chart below shows that BRICS versus G7 as a share of purchasing …
Biotechnology has traded basically sideways since the start of 2023.
In the face of higher rates, stronger dollar, inflation, FDA approvals and busts, and an emerging winter season, the ETF IBB has a serenity to it that appears drug-induced if …
Mish in the Media
View Mish's Media Highlights
New to Mish's Daily?
Discover Mish's Modern Family
Mish's Articles
View Mish's article archive
